In this retrospective study, researchers compared overall survival in ICI-treated patients with solid tumors according to COVID-19 mRNA vaccination status, timing, and prior number of vaccines.

Patients reporting combined walking, moderate, and vigorous exercise seven or more times/week have lower odds of POD ...

An integrative literature review evaluated evidence on how competence, compassion, emotional labor, and educational preparation intersect in palliative oncology nursing care.

Pembrolizumab continues to demonstrate a disease-free and overall survival benefit for patients with clear cell renal ...

In patients with extensive-stage small cell lung cancer, adding tarlatamab to durvalumab maintenance therapy significantly ...

Niraparib plus dostarlimab with definitive cisplatin plus radiotherapy improves some outcomes in patients with locally ...

In patients with previously treated advanced/metastatic KRAS G12C NSCLC, divarasib improves survival compared with sotorasib ...

In this phase 2 trial, researchers assessed anhydrous enol-oxaloacetate for potential benefit in breast cancer survivors with moderately severe cancer-related cognitive impairment.

A retrospective study evaluated long-term outcomes and the feasibility of treatment cessation in patients with metastatic HSPC who achieved a response to initial therapy.

In patients with muscle-invasive bladder cancer (MIBC), treatment with neoadjuvant durvalumab and enfortumab vedotin, with or ...

Combining the novel, highly selective HDAC inhibitor HBI-8000 with nivolumab significantly improves PFS in unresectable ...

The intismeran/pembrolizumab combination significantly improved relapse-free and distant metastasis-free survival in advanced ...